Lefamulin, a recently approved novel antibacterial agent to fight against community-acquired bacterial pneumonia

Lefamulin, a recently approved novel antibacterial agent to fight against community-acquired bacterial pneumonia

Bibliographic Details
Main Authors: Shouvik Choudhury, Moumita Bala, Dwaipayan Sarathi Chakraborty, Sandeep Lahiry
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Lung India
Online Access:http://www.lungindia.com/article.asp?issn=0970-2113;year=2021;volume=38;issue=3;spage=300;epage=301;aulast=Choudhury

Internet

http://www.lungindia.com/article.asp?issn=0970-2113;year=2021;volume=38;issue=3;spage=300;epage=301;aulast=Choudhury

Similar Items